Viatris Inc.: Psychotic Disorders trials

The registry lists 12 Psychotic Disorders studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 2 1Phase 3 3Phase 4 7No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeTerminatedNCT00748566Phase 4Results posted
• Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To ZiprasidoneCompletedNCT00406315Phase 4Results posted
• A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic DisordersCompletedNCT00650611Phase 2
• A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective DisorderCompletedNCT00650429Phase 4
• A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic DrugsCompletedNCT00649064Phase 4
• A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective DisorderTerminatedNCT00645229Phase 3
• A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of PsychosisCompletedNCT00644800Phase 4
• A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized PatientsCompletedNCT00634348Phase 4
• Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.CompletedNCT00454883
• Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic PatientsCompletedNCT00159770Phase 3
• Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind StudyCompletedNCT00145444Phase 3
• Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective DisorderCompletedNCT00137020Phase 4